SINCLAIR PHARMA PLC Toevoegen aan een lijst
Managers
| Managers | Titel | Leeftijd | Van |
|---|---|---|---|
Miguel Pardos
CEO | Chief Executive Officer | - | 01-06-22 |
Santiago Calavia
PRN | Corporate Officer/Principal | - | - |
Julie Moreau
PRN | Corporate Officer/Principal | - | - |
Kamal Abbasi
PRN | Corporate Officer/Principal | - | - |
Jayne Burrell
LAW | General Counsel | 50 | 02-01-15 |
Nairn McMaster
PRN | Corporate Officer/Principal | - | 01-07-11 |
Emilie Croissant
SAM | Sales & Marketing | - | - |
Besturend
| Besturend | Titel | Leeftijd | Van |
|---|---|---|---|
Cheng Wei Liu
CHM | Chairman | 50 | - |
Miguel Pardos
CEO | Chief Executive Officer | - | 01-06-22 |
Gen Li
BRD | Director/Board Member | - | 27-04-23 |
Aandelenklasse
| Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
|---|---|---|---|---|---|
| Aandeel A | 1 | 580 157 084 | 315 849 061 ( 54,44 %) | 0 | 54,44 % |
Bedrijfsgegevens
Sinclair Pharma Ltd.
Whitfield Court 30-32 Whitfield Street
W1T 2RQ, London
+44 20 7467 6920
http://www.sinclairpharma.com
Sector
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| +19,98% | 43,48 mld. | |
| +20,67% | 22,65 mld. | |
| +14,56% | 14,73 mld. | |
| +44,72% | 12,04 mld. | |
| -8,37% | 7,08 mld. | |
| -0,05% | 6,79 mld. | |
| -8,87% | 5,73 mld. | |
| +11,90% | 5,47 mld. | |
| -2,27% | 4,81 mld. |
